Literature DB >> 7687865

Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.

M Gessler1, A König, J Moore, S Qualman, K Arden, W Cavenee, G Bruns.   

Abstract

Wilms' tumor is a childhood nephroblastoma that is postulated to arise through the inactivation of a tumor suppressor gene by a two-hit mechanism. A candidate 11p13 Wilms' tumor gene, WT1, has been cloned and shown to encode a zinc finger protein. Patients with the WAGR syndrome (Wilm's tumor, aniridia, genitourinary abnormalities, and mental retardation) have a high risk of developing Wilms' tumor and they carry constitutional deletions of one chromosome 11 allele encompassing the WT1 gene. Analysis of the remaining WT1 allele in a Wilms' tumor from a WAGR patient revealed the deletion of a single nucleotide in exon 7. This mutation likely played a key role in tumor formation, as it prevents translation of the DNA-binding zinc finger domain that is essential for the function of the WT1 polypeptide as a transcriptional regulator.

Entities:  

Mesh:

Year:  1993        PMID: 7687865     DOI: 10.1002/gcc.2870070304

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Software and database for the analysis of mutations in the human WT1 gene.

Authors:  C Jeanpierre; C Béroud; P Niaudet; C Junien
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

2.  Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome.

Authors:  M l He; L Wen; C E Campbell; J Y Wu; Y Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

3.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

Review 4.  Towards an understanding of Wilms' tumour.

Authors:  K A Williamson; V Van Heyningen
Journal:  Int J Exp Pathol       Date:  1994-06       Impact factor: 1.925

5.  Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.

Authors:  Veronica van Heyningen; Jan M N Hoovers; Jan de Kraker; John A Crolla
Journal:  J Med Genet       Date:  2007-07-14       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.